secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cyclerion Therapeutics, Inc. (CYCN)
CIK:        0001755237
Form:       8-K
Filed at:   2022-11-29T23:59:59+00:00
Accession:  0000950170-22-025791
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclerion gets 180-day bid price extension; transfers to Nasdaq Capital Market
------------------------------------------------------------------------------

- Nasdaq granted extension to May 29, 2023 to regain $1.00 minimum bid price compliance.
- Company transferred from Nasdaq Global Market to Capital Market on Nov 25, 2022.
- Bid price below $1.00 for 30 consecutive business days; needs 10 consecutive days at $1.00+.
- If not cured by May 29, 2023, common stock will be delisted (subject to appeal).
- Company intends to cure deficiency via reverse stock split, if necessary.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1755237/000095017022025791/0000950170-22-025791-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1755237/000095017022025791/cycn-20221129.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-025791

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer